Global Respiratory Care Devices Market Size By Type (Therapeutic device, Monitoring device), By Application (Household, Hospital), By Region, And Segment Forecasts, 2023 to 2032

The Global Respiratory Care Devices Market was valued at USD 18.6 billion in 2023 and is projected to reach USD 32.4 billion by 2031, growing at a CAGR of 7.2% during the forecast period of 2023–2031. The market is primarily driven by the rising prevalence of respiratory diseases such as COPD, asthma, and sleep apnea, alongside an aging global population. Increasing air pollution, technological advancements in respiratory therapeutics, and the growing awareness of early diagnosis and treatment options are also fueling market demand. Additionally, the COVID-19 pandemic significantly accelerated the adoption of respiratory care devices globally, boosting market expansion.

Drivers:

1. Growing Burden of Respiratory Diseases:

Rising incidence of chronic respiratory disorders, especially in developed and industrializing nations, is one of the key drivers for the market. Conditions such as asthma, chronic bronchitis, and pulmonary hypertension demand continuous respiratory care.

2. Technological Advancements in Respiratory Devices:

Innovations such as portable oxygen concentrators, smart inhalers, and non-invasive ventilation solutions are driving adoption, especially for home care settings.

3. Rising Demand for Home Healthcare:

The shift towards home-based care and the growing elderly population requiring long-term respiratory support is creating sustained demand for portable and user-friendly respiratory devices.

Restraints:

1. High Cost of Devices and Maintenance:

Advanced respiratory care devices involve significant initial and recurring costs, limiting their accessibility in low-income and rural settings.

2. Limited Access in Developing Regions:

Inadequate healthcare infrastructure and lower healthcare spending in certain regions may restrict the adoption of respiratory care technologies.

Opportunity:

1. Untapped Markets in Emerging Economies:

Countries like India, China, Brazil, and regions in Africa present vast growth potential owing to rising healthcare investments and increasing public health awareness.

2. Integration of AI and Remote Monitoring:

The integration of artificial intelligence, IoT, and telehealth into respiratory devices enables real-time monitoring and personalized therapy, opening up new growth avenues.

Market by System Type Insights:

The Therapeutic Devices segment dominated the market in 2023. This includes CPAP, BiPAP, nebulizers, and ventilators, which are widely used in both clinical and home settings. These devices are crucial for managing both chronic and acute respiratory disorders. The segment is expected to maintain its dominance due to increasing ICU admissions and the rising preference for non-invasive ventilation support.

Market by End-use Insights:

In 2023, Hospitals emerged as the largest end-use segment, accounting for more than 45% of total revenue. This is due to the large volume of patients, critical care units, and the availability of advanced infrastructure. However, the Home Healthcare segment is anticipated to grow at the fastest pace due to the rise in chronic conditions requiring continuous monitoring and treatment outside clinical settings.

Market by Regional Insights:

North America led the global respiratory care devices market in 2023, attributed to high healthcare spending, awareness, and presence of major players. Asia-Pacific is expected to witness the fastest growth during the forecast period, driven by increasing pollution levels, smoking rates, and rapid expansion of healthcare facilities in countries like China and India.

Competitive Scenario:

Key players in the global respiratory care devices market include:

Philips Respironics

ResMed Inc.

Fisher & Paykel Healthcare

Medtronic plc

Drägerwerk AG & Co. KGaA

GE Healthcare

Vyaire Medical

Masimo Corporation

Invacare Corporation

Chart Industries, Inc.

These companies are focusing on technological innovation, strategic partnerships, and global expansion to maintain competitive advantages. For instance:

In 2023, ResMed launched a next-gen portable CPAP device with remote monitoring capability.

In 2024, Philips expanded its wearable oxygen therapy portfolio for COPD patients.

In 2025, GE Healthcare unveiled an AI-enabled ventilator designed for use in both ICUs and transport settings.

Scope of Work – Global Respiratory Care Devices Market

Report Metric Details

Market Size (2023) USD 18.6 billion

Projected Market Size (2031) USD 32.4 billion

CAGR (2023–2031) 7.2%

Key Segments System Type (Therapeutic, Monitoring, Diagnostic), End-use (Hospitals, Homecare, Clinics), Region

Growth Drivers Increasing prevalence of respiratory diseases, growing geriatric population, technological innovations

Opportunities Market expansion in emerging economies, integration of AI and remote respiratory monitoring

Key Market Developments:

2023: ResMed introduced a cloud-connected portable CPAP device, enhancing home sleep therapy capabilities.

2024: Philips launched a new line of wearable, smart oxygen concentrators with long battery life for COPD patients.

2025: GE Healthcare developed an AI-integrated multi-use ventilator with remote diagnostics and predictive maintenance features.

FAQs:

1) What is the current market size of the Global Respiratory Care Devices Market?

The market was valued at USD 18.6 billion in 2023.

2) What is the major growth driver of the Global Respiratory Care Devices Market?

The increasing prevalence of respiratory diseases and growing demand for home-based respiratory care are the major drivers.

3) Which is the largest region during the forecast period in the Global Respiratory Care Devices Market?

North America is currently the largest region, while Asia-Pacific is expected to grow the fastest.

4) Which segment accounted for the largest market share in Global Respiratory Care Devices Market?

The Therapeutic Devices segment held the largest market share in 2023.

5) Who are the key market players in the Global Respiratory Care Devices Market?

Philips Respironics, ResMed Inc., Fisher & Paykel Healthcare, Medtronic plc, and GE Healthcare are among the leading players.